Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
The American Journal of Psychiatry|August 1, 1996
cAMP-dependent protein kinase activity in major depressionR C Shelton, D H Mainer, F SulserJournal of Affective Disorders|August 21, 2001
Cross-talk between PKA and PKC in human fibroblasts: what are the pharmacotherapeutic implications?D H Manier, R C Shelton, F SulserJournal of Neural Transmission (Vienna, Austria : 1996)|January 17, 2002
Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P?D H Manier, R C Shelton, F SulserNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1996
Beta-adrenoceptor-linked protein kinase A (PKA) activity in human fibroblasts from normal subjects and from patients with major depressionD H Manier, A Eiring, R C Shelton, et al.Journal of Affective Disorders|December 2, 2000
Human fibroblasts as a relevant model to study signal transduction in affective disordersD H Manier, R C Shelton, T C Ellis, et al.Molecular Biotechnology|December 1, 2001
Detection of an mRNA polymorphism by differential displayS Liang, S P Rossby, P Liang, et al.The Journal of Clinical Psychiatry|March 1, 1987
Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disordersF SulserThe Journal of Clinical Psychiatry|October 1, 1986
Update on neuroreceptor mechanisms and their implication for the pharmacotherapy of affective disordersF SulserNeuropharmacology|February 1, 1984
Regulation and function of noradrenaline receptor systems in brain. Psychopharmacological aspectsF SulserPharmakopsychiatrie, Neuro-Psychopharmakologie|January 1, 1978
Functional aspects of the norepinephrine receptor coupled adenylate cyclase system in the limbic forebrain and its modification by drugs which precipitate or alleviate depression: molecular approaches to an understanding of affective disordersF SulserPageof 9